Development of a 89Zr radiolabeled anti-CD33 antibody for PET imaging of Acute Myeloid Leukemia

被引：0
|
作者：
Buckway, Brandon [1 ]
Burrell, Lance [2 ]
Shami, Paul [2 ]
Kosak, Ken [2 ]
Lum, David [2 ]
Yap, Jeffrey [1 ]
机构：
[1] Huntsman Canc Inst, Ctr Quantitat Canc Imaging, Salt Lake City, UT USA
[2] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1053
引用
收藏
页数：2
相关论文
共 50 条
  • [1] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Jurcic, Joseph G.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 65 - 73
  • [2] What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
    Joseph G. Jurcic
    Current Hematologic Malignancy Reports, 2012, 7 : 65 - 73
  • [3] RADIOLABELED ANTI-CD33 MONOCLONAL-ANTIBODY M195 FOR MYELOID LEUKEMIAS
    JURCIC, JG
    CARON, PC
    NIKULA, TK
    PAPADOPOULOS, EB
    FINN, RD
    GANSOW, OA
    MILLER, WH
    GEERLINGS, MW
    WARRELL, RP
    LARSON, SM
    SCHEINBERG, DA
    CANCER RESEARCH, 1995, 55 (23) : S5908 - S5910
  • [4] ANTI-CD33 CHIMERIC ANTIGEN RECEPTOR THERAPY FOR ACUTE MYELOID LEUKEMIA
    O'Hear, Carol
    Heiber, Joshua
    Geiger, Terrence
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S1 - S1
  • [5] Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
    O'Hear, Carol
    Heiber, Joshua F.
    Schubert, Ingo
    Fey, Georg
    Geiger, Terrence L.
    HAEMATOLOGICA, 2015, 100 (03) : 336 - 344
  • [6] Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia
    O'Hear, Carol E.
    Heiber, Joshua
    Geiger, Terrence L.
    BLOOD, 2013, 122 (21)
  • [7] THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA
    APPELBAUM, FR
    MATTHEWS, DC
    EARY, JF
    BADGER, CC
    KELLOGG, M
    PRESS, OW
    MARTIN, PJ
    FISHER, DR
    NELP, WB
    THOMAS, ED
    BERNSTEIN, ID
    TRANSPLANTATION, 1992, 54 (05) : 829 - 833
  • [8] An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker
    Hamann, PR
    Hinman, LM
    Beyer, CF
    Lindh, D
    Upeslacis, J
    Flowers, DA
    Bernstein, I
    BIOCONJUGATE CHEMISTRY, 2002, 13 (01) : 40 - 46
  • [9] Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Mulford, D
    Chaitanya, D
    McDevitt, M
    Sgouros, G
    Finn, R
    Larson, S
    Apostolidis, C
    Morgenstern, A
    Scheinberg, D
    Jurcic, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 526 - 526
  • [10] Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia
    Laing, Alison A.
    Harrison, Christine J.
    Gibson, Brenda E. S.
    Keeshan, Karen
    EXPERIMENTAL HEMATOLOGY, 2017, 54 : 40 - 50
12345